Postpoliomyelitis Syndrome PPS
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) All PPS subjects who participated in the trial by Horemans et al in 1999-2000* (2) All controls who participated in the study described by Drost et al in the same period**;* Horemans HL, Nollet F, Beelen A et al. Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement. J Neurol Neurosurg Psychiatry. 2003;74:1655-1661 **Drost G, Stegeman DF, Schillings ML et al. Motor unit characteristics in healthy subjects and those with postpoliomyelitis syndrome: a high-density surface EMG study. Muscle Nerve. 2004;30:269-276.
Exclusion criteria
Exclusion criteria: All participants of the trials of Horemans et al and Drost et al are eligible for participation unless they suffer from: (1) Legal incompetence (incapacity), e.g. due to dementia (2) Motor neuron disease or neurological disease that affects voluntary control of the quadriceps muscle under investigation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in maximal quadriceps strength and motor unit size since baseline measurements 10 years ago. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary parameters are changes in walking capacity, daily walking activity, physical functioning, fatigue and additional motor unit characteristics. | — |
Countries
Netherlands